Guorong Fan | Pharmaceutical Analysis | Best Researcher Award

Prof. Guorong Fan, Shanghai Jiao Tong University, China.

Guorong Fan is a Professor at the School of Pharmacy, Shanghai Jiao Tong University. He has led over 50 major research projects, including national initiatives on new drug development, pharmacokinetics, and traditional Chinese medicine modernization. With 140+ SCI publications, he is an authority in pharmaceutical analysis, HPLC, and LC-MS. He has collaborated internationally with institutions like UCLA and the Free University of Brussels. A distinguished editorial board member, he has mentored over 60 doctoral and master’s students and holds patents in advanced drug analysis. His contributions continue to impact the global pharmaceutical research community.

Publivation Profiles

SCOPUS

Education and Experience

Education:

Ph.D. in Pharmaceutical Sciences
M.Sc. in Pharmacy
B.Sc. in Pharmacy

Professional Experience:

Professor, School of Pharmacy, Shanghai Jiao Tong University
Led 50+ major research projects in drug metabolism & kinetics
Published 140+ SCI papers in top journals
Editorial board member of leading pharmaceutical journals
Conducted collaborative research with UCLA & Free University of Brussels

Suitability summary

Professor Guorong Fan, a distinguished researcher at the School of Pharmacy, Shanghai Jiao Tong University, is a highly suitable candidate for the Best Researcher Award due to his groundbreaking contributions to pharmaceutical analysis, pharmacokinetics, and clinical pharmacy. With a prolific academic career spanning over 140 SCI publications, he has significantly advanced the fields of drug metabolism, bioavailability evaluation, and innovative analytical techniques. His work has shaped global pharmaceutical research and development, making him a leading figure in the industry.

Professional Development

Guorong Fan has played a crucial role in advancing pharmaceutical sciences through international collaborations, drug formulation studies, and pharmacokinetics research. His expertise in HPLC, LC-MS, and clinical drug monitoring has led to high-impact innovations in the field. As an editorial board member, he ensures the quality and integrity of pharmaceutical research publications. Additionally, his work on preclinical drug metabolism and kinetic studies has contributed to several drug approvals. Through mentorship and industry partnerships, he continues to shape the future of pharmaceutical analysis and drug development globally.

Research Focus

Guorong Fan’s research focuses on pharmaceutical analysis, pharmacokinetics, and clinical pharmacy. He specializes in drug metabolism and kinetics, particularly in HPLC and LC-MS techniques for precise drug concentration measurement. His research includes bioavailability evaluation, therapeutic drug monitoring, and analytical pharmacology. By leveraging cutting-edge analytical methods, he has contributed to the modernization of traditional Chinese medicine and innovative drug development. His studies on anti-tuberculosis and anti-AIDS drug pharmacokinetics have had a significant global impact. Through international collaborations, his work continues to drive advancements in drug analysis and personalized medicine.

Awards And Honours

Best Researcher Award
Expert Reviewer for the National Natural Science Foundation of China
Vice Chairman, Home Pharmacy Service Pharmacist Branch, Chinese Pharmacist Association
Executive Member, Drug Evaluation Committee, Chinese Research Hospital Association
Chairman, Drug Analysis Professional Committee, Shanghai Pharmaceutical Society
Editorial Board Member, Chinese Journal of New Drugs & Clinical Medicine
Recipient of multiple national and international research grants
Leader in over 50 major pharmaceutical research projects
Contributor to drug policy and development in China
Recognized for mentoring over 60 Ph.D. and master’s students

Publication Top Noted

Differences in hypersensitivity reactions and gadolinium deposition disease based on global databases – BMC Medicine, 2024 – Cited by: 1
Five years of safety profile of bevacizumab: pharmacovigilance and RCT analysis – Journal of Pharmaceutical Health Care and Sciences, 2024 – Cited by: 5
Advances in therapeutic drug monitoring of invasive fungal disease – China Pharmacy, 2024
Altered biliary microbial and metabolic profile in NAFLD and cholelithiasis – Clinics and Research in Hepatology and Gastroenterology, 2024
Cost-utility analysis and drug pricing for tirzepatide vs. semaglutide in China – Diabetes, Obesity and Metabolism, 2024 – Cited by: 2
Mining of anaphylaxis associated with oxaliplatin using FDA adverse event database – Chinese Journal of Hospital Pharmacy, 2024